Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-25-000266
Filing Date
2025-10-29
Accepted
2025-10-29 16:43:55
Documents
79
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS, INC. 10-Q 9-30-2025 form10q.htm   iXBRL 10-Q 1281026
7 EXHIBIT 31.1 ex31-1.htm EX-31.1 8514
8 EXHIBIT 31.2 ex31-2.htm EX-31.2 8441
9 EXHIBIT 32.1 ex32-1.htm EX-32.1 4876
  Complete submission text file 0000874015-25-000266.txt   6821854

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA ions-20250930.xsd EX-101.SCH 56472
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE ions-20250930_def.xml EX-101.DEF 300440
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE ions-20250930_lab.xml EX-101.LAB 495412
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE ions-20250930_pre.xml EX-101.PRE 311991
6 INLINE XBRL TAXONOMY EXTENSION - CALCULATION LINKBASE DOCUMENT ions-20250930_cal.xml EX-101.CAL 69369
82 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 944932
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 251430586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)